Glimiscore MV1 Tablet 15's

Glimiscore MV1 Tablet 15's

Prescription drug
Manufacturer / Marketer : CRESHA
About: Glimiscore MV1 is a triple antidiabetic combining low‑dose glimepiride, metformin, and voglibose for type 2 diabetes.
Usage Instructions: Taken with main meals, dose individualized by doctor.
Benefits: Addresses fasting and post‑prandial hyperglycemia with lower sulfonylurea dose.
How it Works: Uses sulfonylurea, biguanide, and alpha‑glucosidase inhibition pathways similar to Glimisave MV regimens.
Side Effects: GI discomfort, flatulence, risk of hypoglycemia.
Safety Advice: Maintain consistent carbohydrate intake and monitor blood glucose.
Storage: Store at room temperature below 25–30°C.
₹114.08 MRP: ₹124.00 Save ₹9.92 (8%)
Inclusive of all taxes
Quantity

Expiry Icon
Fresh Stock
Guaranteed
Return Icon
Secure & Hygienic
Packaging
Authentic Icon
Verified & Trusted
Supplements
Quality Icon
Secure
Payment
About: Glimiscore MV1 is a triple antidiabetic combining low‑dose glimepiride, metformin, and voglibose for type 2 diabetes.
Usage Instructions: Taken with main meals, dose individualized by doctor.
Benefits: Addresses fasting and post‑prandial hyperglycemia with lower sulfonylurea dose.
How it Works: Uses sulfonylurea, biguanide, and alpha‑glucosidase inhibition pathways similar to Glimisave MV regimens.
Side Effects: GI discomfort, flatulence, risk of hypoglycemia.
Safety Advice: Maintain consistent carbohydrate intake and monitor blood glucose.
Storage: Store at room temperature below 25–30°C.

Related Products